A Phase 1, Three-Part, Three-Period, Open-Label, Randomized, Single Dose, Crossover Interaction Study, in Healthy Male Subjects to Investigate the Potential for a Pharmacokinetic Drug-Drug Interaction After Co-Administration of DS-5565 and Metformin

Trial Profile

A Phase 1, Three-Part, Three-Period, Open-Label, Randomized, Single Dose, Crossover Interaction Study, in Healthy Male Subjects to Investigate the Potential for a Pharmacokinetic Drug-Drug Interaction After Co-Administration of DS-5565 and Metformin

Completed
Phase of Trial: Phase I

Latest Information Update: 20 May 2017

At a glance

  • Drugs Mirogabalin (Primary) ; Metformin
  • Indications Neuropathic pain
  • Focus Pharmacokinetics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 20 May 2017 Results presented at the 36th Annual Scientific Meeting of the American Pain Society
    • 19 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top